Self-delivery of a metal-coordinated anti-angiogenic nanodrug with GSH depleting ability for synergistic chemo-phototherapy
Synergistic chemo-phototherapy has offered tremendous potential in cancer treatment. Nevertheless, nanosystems usually suffer from the complexity of multicomponents (polymeric or inorganic materials), which results in carrier-related toxicity issues. Moreover, the GSH over-expression of tumor cells...
Saved in:
Published in | Biomaterials science Vol. 11; no. 21; pp. 7132 - 7145 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Cambridge
Royal Society of Chemistry
24.10.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Synergistic chemo-phototherapy has offered tremendous potential in cancer treatment. Nevertheless, nanosystems usually suffer from the complexity of multicomponents (polymeric or inorganic materials), which results in carrier-related toxicity issues. Moreover, the GSH over-expression of tumor cells seriously compromises ROS therapeutic efficiency. Herein, we designed a self-delivered nanodrug
via
Cu(
ii
) coordination-driven co-self-assembly of celastrol (CST, a chemo-drug with anti-angiogenesis activity) and indocyanine green (ICG, a photosensitizer) for synergistic chemo-phototherapy with GSH depletion. The nanodrug was further cloaked by an erythrocyte membrane (RBC) to prolong the circulation time. Within the tumor microenvironment, the nanodrug would be disassembled upon intracellular GSH triggering. Moreover, the released Cu(
ii
) could efficiently deplete the GSH, thus damaging the ROS-scavenging system and amplifying the phototherapeutic efficiency upon laser irradiation. The
in vivo
experiments validated the highly effective accumulation at tumor sites, potent tumor growth inhibition, and inappreciable systemic toxicity. The tumor microenvironment-responsive coordination-driven self-assembled biomimetic nanodrug may hold potential applications in tumor theranostics.
A GSH-responsive Cu(
ii
)-coordinated anti-angiogenic nanodrug was developed by the metal-coordination-driven assembly of an anti-angiogenic drug and photosensitizer for synergistic chemo-phototherapy with GSH depletion. |
---|---|
AbstractList | Synergistic chemo-phototherapy has offered tremendous potential in cancer treatment. Nevertheless, nanosystems usually suffer from the complexity of multicomponents (polymeric or inorganic materials), which results in carrier-related toxicity issues. Moreover, the GSH over-expression of tumor cells seriously compromises ROS therapeutic efficiency. Herein, we designed a self-delivered nanodrug
via
Cu(
ii
) coordination-driven co-self-assembly of celastrol (CST, a chemo-drug with anti-angiogenesis activity) and indocyanine green (ICG, a photosensitizer) for synergistic chemo-phototherapy with GSH depletion. The nanodrug was further cloaked by an erythrocyte membrane (RBC) to prolong the circulation time. Within the tumor microenvironment, the nanodrug would be disassembled upon intracellular GSH triggering. Moreover, the released Cu(
ii
) could efficiently deplete the GSH, thus damaging the ROS-scavenging system and amplifying the phototherapeutic efficiency upon laser irradiation. The
in vivo
experiments validated the highly effective accumulation at tumor sites, potent tumor growth inhibition, and inappreciable systemic toxicity. The tumor microenvironment-responsive coordination-driven self-assembled biomimetic nanodrug may hold potential applications in tumor theranostics. Synergistic chemo-phototherapy has offered tremendous potential in cancer treatment. Nevertheless, nanosystems usually suffer from the complexity of multicomponents (polymeric or inorganic materials), which results in carrier-related toxicity issues. Moreover, the GSH over-expression of tumor cells seriously compromises ROS therapeutic efficiency. Herein, we designed a self-delivered nanodrug via Cu(ii) coordination-driven co-self-assembly of celastrol (CST, a chemo-drug with anti-angiogenesis activity) and indocyanine green (ICG, a photosensitizer) for synergistic chemo-phototherapy with GSH depletion. The nanodrug was further cloaked by an erythrocyte membrane (RBC) to prolong the circulation time. Within the tumor microenvironment, the nanodrug would be disassembled upon intracellular GSH triggering. Moreover, the released Cu(ii) could efficiently deplete the GSH, thus damaging the ROS-scavenging system and amplifying the phototherapeutic efficiency upon laser irradiation. The in vivo experiments validated the highly effective accumulation at tumor sites, potent tumor growth inhibition, and inappreciable systemic toxicity. The tumor microenvironment-responsive coordination-driven self-assembled biomimetic nanodrug may hold potential applications in tumor theranostics. Synergistic chemo-phototherapy has offered tremendous potential in cancer treatment. Nevertheless, nanosystems usually suffer from the complexity of multicomponents (polymeric or inorganic materials), which results in carrier-related toxicity issues. Moreover, the GSH over-expression of tumor cells seriously compromises ROS therapeutic efficiency. Herein, we designed a self-delivered nanodrug via Cu( ii ) coordination-driven co-self-assembly of celastrol (CST, a chemo-drug with anti-angiogenesis activity) and indocyanine green (ICG, a photosensitizer) for synergistic chemo-phototherapy with GSH depletion. The nanodrug was further cloaked by an erythrocyte membrane (RBC) to prolong the circulation time. Within the tumor microenvironment, the nanodrug would be disassembled upon intracellular GSH triggering. Moreover, the released Cu( ii ) could efficiently deplete the GSH, thus damaging the ROS-scavenging system and amplifying the phototherapeutic efficiency upon laser irradiation. The in vivo experiments validated the highly effective accumulation at tumor sites, potent tumor growth inhibition, and inappreciable systemic toxicity. The tumor microenvironment-responsive coordination-driven self-assembled biomimetic nanodrug may hold potential applications in tumor theranostics. A GSH-responsive Cu( ii )-coordinated anti-angiogenic nanodrug was developed by the metal-coordination-driven assembly of an anti-angiogenic drug and photosensitizer for synergistic chemo-phototherapy with GSH depletion. |
Author | Lu, Weihong Lin, YanLing Li, Yang Huang, Cailin Zhu, Fukai Tu, Ruiqin |
AuthorAffiliation | Minnan Normal University Chinese Academy of Sciences Department of Gynecology Zhongshan Hospital Department of Obstetrics and Gynecology Department of Translational Medicine & Xiamen Key Laboratory of Rare Earth Photoelectric Functional Materials Haixi Institute Xiamen Institute of Rare-Earth Materials Engineering Technological Center of Mushroom Industry Zhongshan Hospital (Xiamen) Xiamen Clinical Research Center for Cancer Therapy Fudan University CAS Key Laboratory of Design and Assembly of Functional Nanostructures Fujian Institute of Research on the Structure of Matter |
AuthorAffiliation_xml | – name: Chinese Academy of Sciences – name: Xiamen Clinical Research Center for Cancer Therapy – name: Minnan Normal University – name: Department of Gynecology – name: Engineering Technological Center of Mushroom Industry – name: Department of Obstetrics and Gynecology – name: Xiamen Institute of Rare-Earth Materials – name: Haixi Institute – name: Fudan University – name: CAS Key Laboratory of Design and Assembly of Functional Nanostructures – name: Zhongshan Hospital – name: Zhongshan Hospital (Xiamen) – name: Fujian Institute of Research on the Structure of Matter – name: Department of Translational Medicine & Xiamen Key Laboratory of Rare Earth Photoelectric Functional Materials |
Author_xml | – sequence: 1 givenname: Fukai surname: Zhu fullname: Zhu, Fukai – sequence: 2 givenname: Cailin surname: Huang fullname: Huang, Cailin – sequence: 3 givenname: YanLing surname: Lin fullname: Lin, YanLing – sequence: 4 givenname: Yang surname: Li fullname: Li, Yang – sequence: 5 givenname: Ruiqin surname: Tu fullname: Tu, Ruiqin – sequence: 6 givenname: Weihong surname: Lu fullname: Lu, Weihong |
BookMark | eNpd0c9L5TAQB_AgLvhjvXgXAl5EqDtt0ub16M_ngsse1HNJk0lfpE1qkqeU_eetPlHYucwcPjMMfPfItvMOCTnM4SwHVv_SrB0A6pp3W2S3AC4yvuD19tfMYIccxPgEcwlRQ5Xvkn_32JtMY29fMEzUGyrpgEn2mfI-aOtkQk2lSzaTrrO-Q2cVddJ5HdYdfbVpRZf3t1Tj2GOyrqOytb1NEzU-0Dg5DJ2Nad5RKxx8Nq588mmFQY7TT_LDyD7iwWffJ4831w-Xt9nd3-Xvy_O7TLGcp0xWQoDS3LRSCQ1QaMlKjWWRFwx13bJai6IqlCmNAtWiWXCBrColayssoGL75GRzdwz-eY0xNYONCvteOvTr2BSLitcAZS5mevwfffLr4ObvZrUAwQWUfFanG6WCjzGgacZgBxmmJofmPYrmil38-YhiOeOjDQ5RfbnvqNgb8G-JWQ |
CitedBy_id | crossref_primary_10_1016_j_ejpb_2024_114348 |
Cites_doi | 10.1016/j.ccr.2021.213828 10.1016/j.cclet.2021.07.041 10.1038/s41571-022-00699-x 10.1002/adma.201707567 10.1016/j.jconrel.2020.10.014 10.1038/s41392-022-01231-4 10.1021/acsnano.1c09171 10.1038/s41591-019-0358-x 10.1016/j.cej.2022.140892 10.1016/j.taap.2019.114785 10.1016/j.pmatsci.2021.100919 10.1002/EXP.20210238 10.1021/acs.nanolett.9b05008 10.1038/s41573-022-00615-z 10.1166/jbn.2012.1398 10.1002/adfm.202206157 10.1016/j.jpha.2022.12.002 10.1038/s41467-023-37315-0 10.1039/D0TB00850H 10.1002/advs.202101101 10.1016/j.jconrel.2020.02.025 10.3390/molecules16097880 10.1016/j.phrs.2022.106487 10.1182/blood-2006-10-050807 10.1021/jacs.1c03788 10.1016/j.nantod.2020.100946 10.7150/thno.46728 10.4155/ppa-2017-0035 10.3390/molecules24112162 10.1021/acs.chemrev.0c00977 10.1038/s41467-018-03473-9 10.1126/sciadv.aay9035 10.1038/nrclinonc.2017.44 10.1016/j.ejmech.2020.112081 10.1021/acsnano.6b04695 10.1016/j.apsb.2022.02.027 10.1038/emm.2007.78 10.1021/acsnano.9b05425 |
ContentType | Journal Article |
Copyright | Copyright Royal Society of Chemistry 2023 |
Copyright_xml | – notice: Copyright Royal Society of Chemistry 2023 |
DBID | AAYXX CITATION 7SR 8BQ 8FD JG9 7X8 |
DOI | 10.1039/d3bm00994g |
DatabaseName | CrossRef Engineered Materials Abstracts METADEX Technology Research Database Materials Research Database MEDLINE - Academic |
DatabaseTitle | CrossRef Materials Research Database Engineered Materials Abstracts Technology Research Database METADEX MEDLINE - Academic |
DatabaseTitleList | CrossRef Materials Research Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Engineering |
EISSN | 2047-4849 |
EndPage | 7145 |
ExternalDocumentID | 10_1039_D3BM00994G d3bm00994g |
GroupedDBID | -JG 0-7 0R~ 4.4 53G 705 AAEMU AAGNR AAIWI AANOJ ABASK ABDVN ABGFH ABRYZ ACGFS ACIWK ACLDK ADMRA AENEX AETIL AFOGI AFVBQ AGRSR AGSTE AKBGW ALMA_UNASSIGNED_HOLDINGS ANUXI ASKNT AUDPV BLAPV BSQNT C6K EBS ECGLT EE0 EF- H13 HZ~ H~N J3I O-G O9- OK1 RAOCF RCNCU RPMJG RRC RSCEA RVUXY AAHBH AAJAE AARTK AAWGC AAXHV AAYXX ABEMK ABJNI ABPDG ABXOH ADSRN AEFDR AENGV AESAV AFLYV AGEGJ AHGCF APEMP CITATION GGIMP 7SR 8BQ 8FD JG9 7X8 |
ID | FETCH-LOGICAL-c314t-a6770cd4fbac7d002da35de52123ed9b39d7262cf5fc0cbef847e365a3b6e2063 |
ISSN | 2047-4830 |
IngestDate | Fri Oct 25 01:06:17 EDT 2024 Thu Oct 10 17:04:34 EDT 2024 Fri Aug 23 01:01:49 EDT 2024 Wed Oct 25 11:00:57 EDT 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 21 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c314t-a6770cd4fbac7d002da35de52123ed9b39d7262cf5fc0cbef847e365a3b6e2063 |
Notes | https://doi.org/10.1039/d3bm00994g Electronic supplementary information (ESI) available. See DOI ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-8950-1212 |
PQID | 2880747054 |
PQPubID | 2047520 |
PageCount | 14 |
ParticipantIDs | rsc_primary_d3bm00994g proquest_journals_2880747054 proquest_miscellaneous_2864900517 crossref_primary_10_1039_D3BM00994G |
PublicationCentury | 2000 |
PublicationDate | 2023-10-24 |
PublicationDateYYYYMMDD | 2023-10-24 |
PublicationDate_xml | – month: 10 year: 2023 text: 2023-10-24 day: 24 |
PublicationDecade | 2020 |
PublicationPlace | Cambridge |
PublicationPlace_xml | – name: Cambridge |
PublicationTitle | Biomaterials science |
PublicationYear | 2023 |
Publisher | Royal Society of Chemistry |
Publisher_xml | – name: Royal Society of Chemistry |
References | Yadav (D3BM00994G/cit9/1) 2018; 7 Zhong (D3BM00994G/cit29/1) 2021; 437 Peng (D3BM00994G/cit11/1) 2012; 8 Liu (D3BM00994G/cit33/1) 2023; 456 Fang (D3BM00994G/cit21/1) 2023; 14 Yang (D3BM00994G/cit38/1) 2021; 143 Ben-Akiva (D3BM00994G/cit28/1) 2020; 6 Luo (D3BM00994G/cit6/1) 2022; 9 Shan (D3BM00994G/cit20/1) 2018; 30 Li (D3BM00994G/cit26/1) 2019; 13 Feng (D3BM00994G/cit4/1) 2019; 25 Song (D3BM00994G/cit10/1) 2011; 16 Karaosmanoglu (D3BM00994G/cit24/1) 2021; 329 Sethi (D3BM00994G/cit7/1) 2007; 109 Ye (D3BM00994G/cit35/1) 2022; 32 Chen (D3BM00994G/cit2/1) 2022; 185 Chen (D3BM00994G/cit40/1) 2020; 10 Koo (D3BM00994G/cit34/1) 2022; 16 Wu (D3BM00994G/cit12/1) 2018; 10 Xiong (D3BM00994G/cit19/1) 2020; 20 Tu (D3BM00994G/cit18/1) 2020; 8 Jana (D3BM00994G/cit30/1) 2022; 2 Nam (D3BM00994G/cit17/1) 2018; 9 Wang (D3BM00994G/cit31/1) 2020; 35 Jin (D3BM00994G/cit1/1) 2023; 22 Jin (D3BM00994G/cit13/1) 2019; 24 Hou (D3BM00994G/cit15/1) 2020; 189 Li (D3BM00994G/cit25/1) 2020; 321 Shibue (D3BM00994G/cit16/1) 2017; 14 Liu (D3BM00994G/cit23/1) 2022; 125 Xu (D3BM00994G/cit32/1) 2021; 8 Hong (D3BM00994G/cit3/1) 2023; 13 Jung (D3BM00994G/cit8/1) 2007; 39 Chen (D3BM00994G/cit39/1) 2016; 10 Chen (D3BM00994G/cit22/1) 2022; 12 Xu (D3BM00994G/cit5/1) 2023; 8 Fang (D3BM00994G/cit27/1) 2023; 20 Xu (D3BM00994G/cit37/1) 2022; 33 Liu (D3BM00994G/cit14/1) 2019; 383 Tang (D3BM00994G/cit36/1) 2021; 121 |
References_xml | – volume: 437 start-page: 213828 year: 2021 ident: D3BM00994G/cit29/1 publication-title: Coord. Chem. Rev. doi: 10.1016/j.ccr.2021.213828 contributor: fullname: Zhong – volume: 33 start-page: 968 year: 2022 ident: D3BM00994G/cit37/1 publication-title: Chin. Chem. Lett. doi: 10.1016/j.cclet.2021.07.041 contributor: fullname: Xu – volume: 20 start-page: 33 year: 2023 ident: D3BM00994G/cit27/1 publication-title: Nat. Rev. Clin Oncol. doi: 10.1038/s41571-022-00699-x contributor: fullname: Fang – volume: 30 start-page: 1707567 year: 2018 ident: D3BM00994G/cit20/1 publication-title: Adv. Mater. doi: 10.1002/adma.201707567 contributor: fullname: Shan – volume: 329 start-page: 805 year: 2021 ident: D3BM00994G/cit24/1 publication-title: J. Controlled Release doi: 10.1016/j.jconrel.2020.10.014 contributor: fullname: Karaosmanoglu – volume: 8 start-page: 51 year: 2023 ident: D3BM00994G/cit5/1 publication-title: Signal Transduction Targeted Ther. doi: 10.1038/s41392-022-01231-4 contributor: fullname: Xu – volume: 9 start-page: 22 year: 2022 ident: D3BM00994G/cit6/1 publication-title: Mil. Med. Res. contributor: fullname: Luo – volume: 16 start-page: 2535 year: 2022 ident: D3BM00994G/cit34/1 publication-title: ACS Nano doi: 10.1021/acsnano.1c09171 contributor: fullname: Koo – volume: 25 start-page: 575 year: 2019 ident: D3BM00994G/cit4/1 publication-title: Nat. Med. doi: 10.1038/s41591-019-0358-x contributor: fullname: Feng – volume: 456 start-page: 140892 year: 2023 ident: D3BM00994G/cit33/1 publication-title: Chem. Eng. J. doi: 10.1016/j.cej.2022.140892 contributor: fullname: Liu – volume: 383 start-page: 114785 year: 2019 ident: D3BM00994G/cit14/1 publication-title: Toxicol. Appl. Pharmacol. doi: 10.1016/j.taap.2019.114785 contributor: fullname: Liu – volume: 125 start-page: 100919 year: 2022 ident: D3BM00994G/cit23/1 publication-title: Prog. Mater. Sci. doi: 10.1016/j.pmatsci.2021.100919 contributor: fullname: Liu – volume: 2 start-page: 20210238 year: 2022 ident: D3BM00994G/cit30/1 publication-title: Exploration doi: 10.1002/EXP.20210238 contributor: fullname: Jana – volume: 20 start-page: 1781 year: 2020 ident: D3BM00994G/cit19/1 publication-title: Nano Lett. doi: 10.1021/acs.nanolett.9b05008 contributor: fullname: Xiong – volume: 22 start-page: 213 year: 2023 ident: D3BM00994G/cit1/1 publication-title: Nat. Rev. Drug Discovery doi: 10.1038/s41573-022-00615-z contributor: fullname: Jin – volume: 8 start-page: 491 year: 2012 ident: D3BM00994G/cit11/1 publication-title: J. Biomed. Nanotechnol. doi: 10.1166/jbn.2012.1398 contributor: fullname: Peng – volume: 32 start-page: 2206157 year: 2022 ident: D3BM00994G/cit35/1 publication-title: Adv. Funct. Mater. doi: 10.1002/adfm.202206157 contributor: fullname: Ye – volume: 13 start-page: 156 year: 2023 ident: D3BM00994G/cit3/1 publication-title: J. Pharm. Anal. doi: 10.1016/j.jpha.2022.12.002 contributor: fullname: Hong – volume: 14 start-page: 1660 year: 2023 ident: D3BM00994G/cit21/1 publication-title: Nat. Commun. doi: 10.1038/s41467-023-37315-0 contributor: fullname: Fang – volume: 8 start-page: 5667 year: 2020 ident: D3BM00994G/cit18/1 publication-title: J. Mater. Chem. B doi: 10.1039/D0TB00850H contributor: fullname: Tu – volume: 8 start-page: 2101101 year: 2021 ident: D3BM00994G/cit32/1 publication-title: Adv. Sci. doi: 10.1002/advs.202101101 contributor: fullname: Xu – volume: 321 start-page: 222 year: 2020 ident: D3BM00994G/cit25/1 publication-title: J. Controlled Release doi: 10.1016/j.jconrel.2020.02.025 contributor: fullname: Li – volume: 16 start-page: 7880 year: 2011 ident: D3BM00994G/cit10/1 publication-title: Molecules doi: 10.3390/molecules16097880 contributor: fullname: Song – volume: 185 start-page: 106487 year: 2022 ident: D3BM00994G/cit2/1 publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2022.106487 contributor: fullname: Chen – volume: 109 start-page: 2727 year: 2007 ident: D3BM00994G/cit7/1 publication-title: Blood doi: 10.1182/blood-2006-10-050807 contributor: fullname: Sethi – volume: 143 start-page: 14530 year: 2021 ident: D3BM00994G/cit38/1 publication-title: J. Am. Chem. Soc. doi: 10.1021/jacs.1c03788 contributor: fullname: Yang – volume: 35 start-page: 100946 year: 2020 ident: D3BM00994G/cit31/1 publication-title: Nano Today doi: 10.1016/j.nantod.2020.100946 contributor: fullname: Wang – volume: 10 start-page: 10290 year: 2020 ident: D3BM00994G/cit40/1 publication-title: Theranostics doi: 10.7150/thno.46728 contributor: fullname: Chen – volume: 7 start-page: 155 year: 2018 ident: D3BM00994G/cit9/1 publication-title: Pharm. Pat. Anal. doi: 10.4155/ppa-2017-0035 contributor: fullname: Yadav – volume: 24 start-page: 2162 year: 2019 ident: D3BM00994G/cit13/1 publication-title: Molecules doi: 10.3390/molecules24112162 contributor: fullname: Jin – volume: 121 start-page: 1981 year: 2021 ident: D3BM00994G/cit36/1 publication-title: Chem. Rev. doi: 10.1021/acs.chemrev.0c00977 contributor: fullname: Tang – volume: 9 start-page: 1074 year: 2018 ident: D3BM00994G/cit17/1 publication-title: Nat. Commun. doi: 10.1038/s41467-018-03473-9 contributor: fullname: Nam – volume: 6 start-page: eaay9035 year: 2020 ident: D3BM00994G/cit28/1 publication-title: Sci. Adv. doi: 10.1126/sciadv.aay9035 contributor: fullname: Ben-Akiva – volume: 10 start-page: 2078 year: 2018 ident: D3BM00994G/cit12/1 publication-title: Am. J. Transl. Res. contributor: fullname: Wu – volume: 14 start-page: 611 year: 2017 ident: D3BM00994G/cit16/1 publication-title: Nat. Rev. Clin Oncol. doi: 10.1038/nrclinonc.2017.44 contributor: fullname: Shibue – volume: 189 start-page: 112081 year: 2020 ident: D3BM00994G/cit15/1 publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2020.112081 contributor: fullname: Hou – volume: 10 start-page: 10049 year: 2016 ident: D3BM00994G/cit39/1 publication-title: ACS Nano doi: 10.1021/acsnano.6b04695 contributor: fullname: Chen – volume: 12 start-page: 3710 year: 2022 ident: D3BM00994G/cit22/1 publication-title: Acta Pharm. Sin. B doi: 10.1016/j.apsb.2022.02.027 contributor: fullname: Chen – volume: 39 start-page: 715 year: 2007 ident: D3BM00994G/cit8/1 publication-title: Exp. Mol. Med. doi: 10.1038/emm.2007.78 contributor: fullname: Jung – volume: 13 start-page: 12912 year: 2019 ident: D3BM00994G/cit26/1 publication-title: ACS Nano doi: 10.1021/acsnano.9b05425 contributor: fullname: Li |
SSID | ssj0000779061 |
Score | 2.3628252 |
Snippet | Synergistic chemo-phototherapy has offered tremendous potential in cancer treatment. Nevertheless, nanosystems usually suffer from the complexity of... |
SourceID | proquest crossref rsc |
SourceType | Aggregation Database Publisher |
StartPage | 7132 |
SubjectTerms | Antiangiogenics Biocompatibility Biomimetics Coordination Depletion Inorganic materials Light therapy Radiation damage Scavenging Self-assembly Toxicity Tumors |
Title | Self-delivery of a metal-coordinated anti-angiogenic nanodrug with GSH depleting ability for synergistic chemo-phototherapy |
URI | https://www.proquest.com/docview/2880747054 https://search.proquest.com/docview/2864900517 |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxELZoe4ED4lURKMgIbpHLxt6Xj6WkDSgthyZSOK382nRFs1ulyaHw5xl7vbsp4VC4rCIn8SqeL-NvxjPfIvQh4CaluUyI1KkiIRBckoaGE5pzanjAKRU2D3l2Ho-m4ddZNOvKbV13yUoeqp9_7Sv5H6vCGNjVdsn-g2XbSWEAXoN94QoWhuu9bHxhrnKizZWtrbitOx0XBtg0URXElEUpLJ2EpSuIKOdFBfMUql-KstLLtU_Bnl6MbDWsk-Ce92vR7rqG8-bWtgU6Hec-WHZRkevLauUbtu4eBhcV8N76B_f9ltolpNeOH69_iKKDkE9SHwu4XVcTVMsZfBfluNlP3agfnG8mKKgrdav7og-Nc2TUqkGEaS1N2nrdwQa66iZp70MhbKYb-3EyqPUmt3x9wKxUqmZyYWluOO92tOYU__xbdjIdj7PJcDbZQXsUfBE4wb2j4eTLuE3EBVZxMR400rWMf-ymvEtWughkZ9k8HsbRkMkT9NjHD_ioBsNT9MCUz9CjDVXJ5-jXHVjgKscCb8EC_wEL3MACW1hggAVuYYE9LDDAAm_AAm_D4gWangwnxyPin7FBFBuEKyLiJAmUDnMpVKJhe9SCRdq4jm6juWRcJzSmKo9yFShpcmAzhsWRYDI2FPjtPtotq9K8RDhUsdZpCIw_gqDWSMkjFuURjZVJKNWyh943i5ld11IqmSuBYDz7zD6duSU_7aGDZp0z_1e7yWhqNZsSCC966F37NjhCe7olSlOt7WfikDvJuR7aB_u09-jM-eoeX36NHnYgPkC7q-XavAHeuZJvPXJ-AxcFjDU |
link.rule.ids | 315,783,787,27936,27937 |
linkProvider | Royal Society of Chemistry |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Self-delivery+of+a+metal-coordinated+anti-angiogenic+nanodrug+with+GSH+depleting+ability+for+synergistic+chemo-phototherapy&rft.jtitle=Biomaterials+science&rft.au=Zhu%2C+Fukai&rft.au=Huang%2C+Cailin&rft.au=Lin%2C+YanLing&rft.au=Li%2C+Yang&rft.date=2023-10-24&rft.eissn=2047-4849&rft.volume=11&rft.issue=21&rft.spage=7132&rft.epage=7145&rft_id=info:doi/10.1039%2Fd3bm00994g&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2047-4830&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2047-4830&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2047-4830&client=summon |